Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Magri

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Presurgery chemotherapy (CT) in locally advanced bladder carcinoma: a feasible and possibly effective approachA Veronesi, V Dal Bo, S Morassut, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Cisplatin and etoposide versus cyclophosphamide, epirubicin and vincristine in small cell lung cancer: a randomised studyA Veronesi, G Cartei, D Crivellari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2006
Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoringD Crivellari, D Lombardi, G Corona, et al.
International Journal of Cancer|August 17, 1999
BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in ItalyM Santarosa, R Dolcetti, M D Magri, et al.
International Journal of Cancer|November 10, 1998
Low incidence of BRCA1 mutations among Italian families with breast and ovarian cancerM Santarosa, A Viel, R Dolcetti, et al.
Tumori|December 31, 1982
Carcinoembryonic antigen (CEA) in the follow-up of disease-free breast cancer patientsA Veronesi, R Talamini, S Longhi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2008
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancerF Puglisi, G G Cardellino, D Crivellari, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Presurgery chemotherapy (CT) in locally advanced bladder carcinoma: a feasible and possibly effective approachA Veronesi, V Dal Bo, S Morassut, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Cisplatin and etoposide versus cyclophosphamide, epirubicin and vincristine in small cell lung cancer: a randomised studyA Veronesi, G Cartei, D Crivellari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2006
Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoringD Crivellari, D Lombardi, G Corona, et al.
International Journal of Cancer|August 17, 1999
BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in ItalyM Santarosa, R Dolcetti, M D Magri, et al.
International Journal of Cancer|November 10, 1998
Low incidence of BRCA1 mutations among Italian families with breast and ovarian cancerM Santarosa, A Viel, R Dolcetti, et al.
Tumori|December 31, 1982
Carcinoembryonic antigen (CEA) in the follow-up of disease-free breast cancer patientsA Veronesi, R Talamini, S Longhi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2008
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancerF Puglisi, G G Cardellino, D Crivellari, et al.
Pageof 3